Antihypertensive treatment escalation and maternal outcomes during expectant management of early-onset preeclampsia with severe features

This publication has 17 references indexed in Scilit:

• Isolated severe systolic hypertension with diastolic <110 mmHg during delivery admission and maternal outcomes: a secondary analysis of the Assessment of Perinatal Excellence cohort
  American Journal of Obstetrics and Gynecology, 2025
• A Method to Quantify Mean Hypertension Treatment Daily Dose Intensity Using Health Care System Data
  JAMA Network Open, 2021
• Pre-eclampsia
  The Lancet, 2016
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
  International Journal of Surgery, 2014
• Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial
  American Journal of Obstetrics and Gynecology, 2013
• Evaluation and management of severe preeclampsia before 34 weeks' gestation
  American Journal of Obstetrics and Gynecology, 2011
• Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model
  The Lancet, 2011
• Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications
  American Journal of Obstetrics and Gynecology, 2007
• Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial
  American Journal of Obstetrics and Gynecology, 1994
• Pre-eclampsia in pregnancies from donor inseminations
  Journal of Reproductive Immunology, 1983